PLATELET PROSTAGLANDIN-D2 DEHYDROGENASE IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS

被引：1

作者：

SUGIYAMA, T ^{[1
]}

OKUMA, M ^{[1
]}

UCHINO, H ^{[1
]}

机构：

[1] KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 1,SAKYO KU,KYOTO 606,JAPAN

来源：

PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 1986年 / 21卷 / 02期

关键词：

D O I：

10.1016/0262-1746(86)90154-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：207 / 220

页数：14

共 28 条

[1] STUDIES ON ANALYSIS AND METABOLISM OF PROSTAGLANDINS [J].

ANGGARD, E .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 180 (APR30) :200-+

[2]

BERTELE V, 1984, BLOOD, V63, P1460

[3] CHARACTERIZATION OF THE PLATELET PROSTAGLANDIN-D2 RECEPTOR - LOSS OF PROSTAGLANDIN-D2 RECEPTORS IN PLATELETS OF PATIENTS WITH MYELOPROLIFERATIVE DISORDERS [J].

COOPER, B ;

AHERN, D .

JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02) :586-590

[4]

COOPER B, 1978, BLOOD, V52, P618

[5] SERUM-ALBUMIN ENHANCES THE IMPAIRMENT OF PLATELET-AGGREGATION WITH THROMBOXANE SYNTHASE INHIBITION BY INCREASING THE FORMATION OF PROSTAGLANDIN-D2 [J].

GRESELE, P ;

DECKMYN, H ;

HUYBRECHTS, E ;

VERMYLEN, J .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (13) :2083-2088

[6] 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE - REVIEW [J].

HANSEN, HS .

PROSTAGLANDINS, 1976, 12 (04) :647-679

[7]

HAYAISHI O, 1982, ADV PHARM THERAPEUTI, V4, P251

[8]

Klingenberg M., 1974, METHOD ENZYMAT AN, V4, P2045, DOI [10. 1016/B978-0-12-091304-6. 50060-4, DOI 10.1016/B978-0-12-091304-6.50060-4]

[9]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[10]

MARCUS AJ, 1978, J LIPID RES, V19, P793

← 1 2 3 →